FDA — authorised 19 August 2011
- Application: BLA125388
- Marketing authorisation holder: SEATTLE GENETICS
- Local brand name: ADCETRIS
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Brentuximab in United States
FDA authorised Brentuximab on 19 August 2011
Marketing authorisations
FDA — authorised 19 August 2011
- Application: BLA125399
- Marketing authorisation holder: SEATTLE GENETICS
- Local brand name: ADCETRIS
- Indication: INJECTABLE — INJECTION
- Status: approved
Other Oncology approved in United States
Frequently asked questions
Is Brentuximab approved in United States?
Yes. FDA authorised it on 19 August 2011; FDA authorised it on 19 August 2011.
Who is the marketing authorisation holder for Brentuximab in United States?
SEATTLE GENETICS holds the US marketing authorisation.